PW02-024 - A case of candle syndrome treated with thalidomide

por Yamazaki, K, Miyamae, T, Yokota, S
Publicado 2013

Inhibition of proliferation and induction of differentiation of glioma cells with Datura stramonium agglutinin

por Sasaki, T, Yamazaki, K, Yamori, T, Endo, T
Publicado 2002

Reply: Appropriate prospective trials are warranted to determine differences between exon 19 deletions and L858R EGFR mutations in non-small cell lung cancer

por Asahina, H, Yamazaki, K, Kinoshita, I
Publicado 2007

Quantum electrodynamics in the non-linear spinor theory and the value of Sommerfield's fine structure constant

por Dürr, H P, Heisenberg, W K, Yamamoto, H, Yamazaki, K
Publicado 1965

PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japa...

por Yokota, S, Nozawa, T, Kanetaka, T, Yamazaki, K, Sato, T, Sakurai, N, Kikuchi, M
Publicado 2013

Experimental studies on toxicity of ethylene glycol alkyl ethers in Japan.

por Nagano, K, Nakayama, E, Oobayashi, H, Nishizawa, T, Okuda, H, Yamazaki, K
Publicado 1984

A cluster randomized trial on the effect of a multifaceted intervention improved the technical quality of diabetes care by primary care physicians: The Japan Diabetes Outcome Inter...

por Hayashino, Y., Suzuki, H., Yamazaki, K., Goto, A., Izumi, K., Noda, M.
Publicado 2015

PReS-FINAL-2172: Efficacy of corticosteroids and intravenous cyclophosphamide for patients with juvenile systemic sclerosis

por Kikuchi, M, Nozawa, T, Kanetaka, T, Nishimura, K, Hara, R, Yamazaki, K, Sato, T, Sakurai, N, Yokota, S
Publicado 2013

PReS-FINAL-2189: Tocillizumab for patients with takayasu arteritis in childhood refractory to conventional therapy

por Yamazaki, K, Kikuchi, M, Nozawa, T, Kanetaka, T, Hara, R, Imagawa, T, Nishimura, K, Sakurai, N, Sato, T, Yokota, S
Publicado 2013

Reversal of freshening trend of Antarctic Bottom Water in the Australian-Antarctic Basin during 2010s

por Aoki, S., Yamazaki, K., Hirano, D., Katsumata, K., Shimada, K., Kitade, Y., Sasaki, H., Murase, H.
Publicado 2020

Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant

por Shimizu, Y, Kinoshita, I, Kikuchi, J, Yamazaki, K, Nishimura, M, Birrer, M J, Dosaka-Akita, H
Publicado 2008

PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy

por Sato, T, Nishimura, K, Nozawa, T, Kanetaka, T, Kikuchi, M, Hara, R, Sakurai, N, Yamazaki, K, Takeuchi, Y, Yokota, S
Publicado 2013

Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach

por Tajima, Y, Yamazaki, K, Makino, R, Nishino, N, Masuda, Y, Aoki, S, Kato, M, Morohara, K, Kusano, M
Publicado 2007

Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions-

por Tajima, Y, Yamazaki, K, Nishino, N, Morohara, K, Yamazaki, T, Kaetsu, T, Suzuki, S, Kawamura, M, Kumagai, K, Kusano, M
Publicado 2004

N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers

por Dosaka-Akita, H, Kinoshita, I, Yamazaki, K, Izumi, H, Itoh, T, Katoh, H, Nishimura, M, Matsuo, K, Yamada, Y, Kohno, K
Publicado 2002

An immunohistochemical investigation of porcine epidemic diarrhoea

por Sueyoshi, M., Tsuda, T., Yamazaki, K., Yoshida, K., Nakazawa, M., Sato, K., Minami, T., Iwashita, K., Watanabe, M., Suzuki, Y., Mori, M.
Publicado 1995

A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations

por Asahina, H, Yamazaki, K, Kinoshita, I, Sukoh, N, Harada, M, Yokouchi, H, Ishida, T, Ogura, S, Kojima, T, Okamoto, Y, Fujita, Y, Dosaka–akita, H, Isobe, H, Nishimura, M
Publicado 2006

Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast c...

por Park, Y, Okamura, K, Mitsuyama, S, Saito, T, Koh, J, Kyono, S, Higaki, K, Ogita, M, Asaga, T, Inaji, H, Komichi, H, Kohno, N, Yamazaki, K, Tanaka, F, Ito, T, Nishikawa, H, Osaki, A, Koyama, H, Suzuki, T
Publicado 2009

Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breas...

por Park, Y, Okamura, K, Mitsuyama, S, Saito, T, Koh, J, Kyono, S, Higaki, K, Ogita, M, Asaga, T, Inaji, H, Komichi, H, Kohno, N, Yamazaki, K, Tanaka, F, Ito, T, Nishikawa, H, Osaki, A, Koyama, H, Suzuki, T
Publicado 2009

A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)

por Okamoto, W., Sakai, K., Makiyama, A., Yamamoto, Y., Shitara, K., Denda, T., Izawa, N., Nakano, Y., Nishina, T., Esaki, T., Hara, H., Miura, Y., Boku, N., Yamazaki, K., Hironaka, S., Misumi, T., Hyodo, I., Muro, K., Nishio, K.
Publicado 2022